Home > Drug Search >
  • Targets: DNA methyltransferase (DNMT)
  •   > 
Drug Filter
Category:
chemistry (8) biology (4)
Status:
Approved (3) Phase Ⅲ (2) Phase Ⅱ (6) Phase Ⅰ (1)
Clinical Stage:
Pending (1) Active (7) Discontinued (1)
Bio-Type:
Monovalent antibody (1) Whole antibody (1) Fab fragment (1)
Company:
Eisai (1) Janssen (1) National Cancer Institute (1) Otsuka (2) Pfizer (1) Effimune (1) Biomedical Primate Research Center (1) OSE Immunotherapeutics (1) Radient (1) TheraMAB (1) City of Hope National Medical Center (1) Sarepta Therapuetics (1) Rexahn Pharmaceuticals (1) Atox Bio (1) Bristol-Myers Squibb (1) Celgene (1)
Indication:
Acute myeloid Leukemia (AML) (2) Bladder cancer (1) Transplant rejection (1) Hematopoietic stem cell transplantation (HSCT) (1) Hepatocellular carcinoma (HCC) (1) Myelodysplastic syndrome (MDS) (2) Ovarian cancer (1) Pancreatic cancer (1) Rheumatoid arthritis (RA) (1) Sjoegren's syndrome (1) Soft tissue infections (1) Solid tumours (2) Systemic lupus erythematosus (2) Anesthesia (1) Plaque psoriasis (1) Pharmaceutical aids (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top